How much faith can we have in pharmacoeconomic analyses?

[KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3].

Zhonghua yi xue za zhi·2019

Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real-world evidence for the concept of 'intensification inertia'.

Diabetic medicine : a journal of the British Diabetic Association·2019

Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial.

Osteoarthritis and cartilage·2011

Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.

International journal of clinical pharmacology and therapeutics·2004

Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom.

Pharmacoepidemiology and drug safety·2002

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.

Clinical therapeutics·2002

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

PharmacoEconomics·2026

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

PharmacoEconomics·2026

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

PharmacoEconomics·2026

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

PharmacoEconomics·2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

PharmacoEconomics·2026

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

PharmacoEconomics·2026

Unscheduled Procedural Sedation Multidisciplinary Delphi Consensus Guidelines, Part 2: Clinical Practice: Approved by the ACEP Board of Directors, April 29, 2026.

Annals of emergency medicine·2026

Performance Improvement as a Foundational Component of the Clinical Model of Family Medicine: Rationale, Concerns, Ways Forward.

Journal of the American Board of Family Medicine : JABFM·2026

Ethical leadership and eudaimonic well-being at work: the roles of organizational identification and caring ethical climate.

Frontiers in psychology·2026

Are accreditation standards fit for measurement uncertainty in clinical laboratories? An analysis of Saudi Arabia's accreditation.

Frontiers in medicine·2026

No More Wild West: The Need for Wellness Professional Standards.

American journal of law & medicine·2026

"Beyond leadership": unraveling the impact of ethical leadership on the most influential factors, an analysis of the mediating role of ethical climate and employee moral identity.

Frontiers in psychology·2026

Related Experiment Videos

How much faith can we have in pharmacoeconomic analyses?

Related Concept Videos

[KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3].

Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real-world evidence for the concept of 'intensification inertia'.

Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial.

Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.

Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom.

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.

Missing Data in Trial-Based Cost-Effectiveness Analysis: The Journey Continues.

External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

A Machine Learning and Large Language Model Tool for Systematic Literature Reviews of Health Economic Evidence: A Validation Study.

A Cost-Effectiveness Model of Semaglutide 2.4 mg, Resmetirom 80 mg, and Resmetirom 100 mg Versus Standard of Care for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review.

Unscheduled Procedural Sedation Multidisciplinary Delphi Consensus Guidelines, Part 2: Clinical Practice: Approved by the ACEP Board of Directors, April 29, 2026.

Performance Improvement as a Foundational Component of the Clinical Model of Family Medicine: Rationale, Concerns, Ways Forward.

Ethical leadership and eudaimonic well-being at work: the roles of organizational identification and caring ethical climate.

Are accreditation standards fit for measurement uncertainty in clinical laboratories? An analysis of Saudi Arabia's accreditation.

No More Wild West: The Need for Wellness Professional Standards.

"Beyond leadership": unraveling the impact of ethical leadership on the most influential factors, an analysis of the mediating role of ethical climate and employee moral identity.

Related Experiment Videos

How much faith can we have in pharmacoeconomic analyses?

Related Concept Videos

Related Articles